{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:56:27Z","timestamp":1790913387799,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.clim.2012.12.004","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T07:38:08Z","timestamp":1355989088000},"page":"131-139","source":"Crossref","is-referenced-by-count":37,"title":["Targeting IL-17 in psoriasis: From cutaneous immunobiology to clinical application"],"prefix":"10.1016","volume":"146","author":[{"given":"Maria-Eugenia","family":"Ariza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall V.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2012.12.004_bb0005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","article-title":"Psoriasis","volume":"7","author":"Perera","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.clim.2012.12.004_bb0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.clindermatol.2007.08.007","article-title":"Psoriasis: epidemiology","volume":"25","author":"Gudjonsson","year":"2007","journal-title":"Clin. Dermatol."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2012.12.004_bb0015","doi-asserted-by":"crossref","first-page":"i77","DOI":"10.1136\/ard.2010.140582","article-title":"Psoriatic arthritis: update on pathophysiology, assessment and management","volume":"70","author":"Mease","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2012.12.004_bb0495","doi-asserted-by":"crossref","unstructured":"B.H. Kaffenberger, H.K. Wong, W. Jarjour, L.A. Andritsos, Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation, J. Am. Acad. Dermatol. (in press), http:\/\/dx.doi.org\/10.1016\/j.jaad.2012.08.021.","DOI":"10.1016\/j.jaad.2012.08.021"},{"key":"10.1016\/j.clim.2012.12.004_bb0025","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1523-1747.2002.01709.x","article-title":"Localization of calcineurin\/NFAT in human skin and psoriasis and inhibition of calcineurin\/NFAT activation in human keratinocytes by cyclosporin A","volume":"118","author":"Al-Daraji","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0030","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1689","article-title":"Getting under the skin: the immunogenetics of psoriasis","volume":"5","author":"Bowcock","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0035","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2012.12.004_bb0040","doi-asserted-by":"crossref","first-page":"819467","DOI":"10.1155\/2012\/819467","article-title":"Th17 response and inflammatory autoimmune diseases","volume":"2012","author":"Waite","year":"2012","journal-title":"Int. J. Inflam."},{"key":"10.1016\/j.clim.2012.12.004_bb0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ncprheum0987","article-title":"New insights into the pathogenesis and genetics of psoriatic arthritis","volume":"5","author":"Nograles","year":"2009","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0050","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1046\/j.1365-2133.2003.05552.x","article-title":"Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study","volume":"149","author":"Gudjonsson","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0055","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.it.2009.07.008","article-title":"Psoriasis\u2014as an autoimmune disease caused by molecular mimicry","volume":"30","author":"Valdimarsson","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0060","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00403-008-0866-x","article-title":"An investigation of antistreptococcal antibody responses in guttate psoriasis","volume":"300","author":"Nahary","year":"2008","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.clim.2012.12.004_bb0065","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.clim.2012.12.004_bb0070","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20090480","article-title":"Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8","volume":"206","author":"Ganguly","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2012.12.004_bb0075","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ng.689","article-title":"Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2","volume":"42","author":"Ellinghaus","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2012.12.004_bb0080","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.4049\/jimmunol.155.8.4078","article-title":"Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris","volume":"155","author":"Menssen","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0085","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3360::AID-IMMU3360>3.0.CO;2-G","article-title":"Selection of conserved TCR VDJ rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgaris","volume":"29","author":"Prinz","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0090","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1046\/j.0022-202x.2001.01494.x","article-title":"Dominant lesional T cell receptor rearrangements persist in relapsing psoriasis but are absent from nonlesional skin: evidence for a stable antigen-specific pathogenic T cell response in psoriasis vulgaris","volume":"117","author":"Vollmer","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0095","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/eji.1830241018","article-title":"T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells","volume":"24","author":"Vollmer","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1189\/JLB.0109046","article-title":"IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines","volume":"86","author":"Ortega","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2012.12.004_bb0105","doi-asserted-by":"crossref","first-page":"e14108","DOI":"10.1371\/journal.pone.0014108","article-title":"Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis","volume":"5","author":"Res","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2012.12.004_bb0110","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/jid.2011.395","article-title":"Psoriasis and other complex trait dermatoses: from Loci to functional pathways","volume":"132","author":"Capon","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0115","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/jid.2012.69","article-title":"Protective effect of human endogenous retrovirus K dUTPase variants on psoriasis susceptibility","volume":"132","author":"Lai","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0120","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1038\/jid.2011.217","article-title":"A human endogenous retrovirus K dUTPase triggers a TH1, TH17 cytokine response: does it have a role in psoriasis?","volume":"131","author":"Ariza","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0125","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nm0307-242","article-title":"Cracking the cytokine code in psoriasis","volume":"13","author":"Nickoloff","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2012.12.004_bb0130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/jid.2008.225","article-title":"Resident and \u201cinflammatory\u201d dendritic cells in human skin","volume":"129","author":"Zaba","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0135","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17, Th22, and Th1 cells are increased in psoriasis","volume":"130","author":"Kagami","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20030451","article-title":"Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris","volume":"199","author":"Lee","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2012.12.004_bb0145","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0150","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","article-title":"A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R","volume":"168","author":"Parham","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0155","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20061099","article-title":"Interleukin-23 drives innate and T cell-mediated intestinal inflammation","volume":"203","author":"Hue","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2012.12.004_bb0160","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.immuni.2010.08.010","article-title":"Interleukin-23 drives intestinal inflammation through direct activity on T cells","volume":"33","author":"Ahern","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2012.12.004_bb0165","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature05969","article-title":"Essential autocrine regulation by IL-21 in the generation of inflammatory T cells","volume":"448","author":"Nurieva","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.clim.2012.12.004_bb0170","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0175","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0180","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ni.1698","article-title":"The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo","volume":"10","author":"McGeachy","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0185","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0190","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0195","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.coi.2008.03.006","article-title":"gammadelta T cells: an important source of IL-17","volume":"20","author":"Roark","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0200","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.4049\/jimmunol.180.8.5167","article-title":"Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion","volume":"180","author":"Rachitskaya","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0205","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2012.12.004_bb0210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2567.2011.03465.x","article-title":"The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases","volume":"134","author":"Pappu","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2012.12.004_bb0215","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/rheumatology\/kep028","article-title":"Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis","volume":"48","author":"Nistala","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2012.12.004_bb0220","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1084\/jem.20071094","article-title":"Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses","volume":"204","author":"Zaba","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2012.12.004_bb0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/jid.2008.194","article-title":"Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells","volume":"129","author":"Zaba","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0230","doi-asserted-by":"crossref","first-page":"43437","DOI":"10.1074\/jbc.M111.299313","article-title":"cAMP-responsive element modulator (CREM)alpha protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus","volume":"286","author":"Rauen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2012.12.004_bb0235","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1074\/jbc.M110.166785","article-title":"Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus","volume":"286","author":"Juang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2012.12.004_bb0240","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.4049\/jimmunol.166.6.4216","article-title":"Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus","volume":"166","author":"Solomou","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0245","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/0961203306069985","article-title":"CAMP response element modulator a expression in patients with systemic lupus erythematosus","volume":"15","author":"Kyttaris","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2012.12.004_bb0500","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaci.2012.04.024","article-title":"IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis","volume":"130","author":"Krueger","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00281-009-0188-x","article-title":"Biology of interleukin-22","volume":"32","author":"Wolk","year":"2010","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.clim.2012.12.004_bb0265","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00109-009-0457-0","article-title":"IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not","volume":"87","author":"Wolk","year":"2009","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.clim.2012.12.004_bb0270","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ni.1770","article-title":"Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells","volume":"10","author":"Trifari","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0275","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1767","article-title":"Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells","volume":"10","author":"Duhen","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0280","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0285","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0290","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.clim.2012.12.004_bb0295","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.4049\/jimmunol.181.10.7420","article-title":"Low expression of the IL-23\/Th17 pathway in atopic dermatitis compared to psoriasis","volume":"181","author":"Guttman-Yassky","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0300","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0305","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.smim.2011.01.006","article-title":"Harnessing dendritic cells in inflammatory skin diseases","volume":"23","author":"Chu","year":"2011","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0310","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.0105-2896.2009.00887.x","article-title":"DC subsets in positive and negative regulation of immunity","volume":"234","author":"Coquerelle","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2012.12.004_bb0315","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.immuni.2008.03.001","article-title":"Th17 cell differentiation: the long and winding road","volume":"28","author":"McGeachy","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2012.12.004_bb0320","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.smim.2007.10.011","article-title":"Transcriptional regulation of Th17 cell differentiation","volume":"19","author":"Ivanov","year":"2007","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0325","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2012.12.004_bb0330","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0733-8635(18)30174-8","article-title":"Role of dendritic cells in benign and malignant lymphocytic infiltrates of the skin","volume":"12","author":"Nestle","year":"1994","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.clim.2012.12.004_bb0335","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1046\/j.1523-1747.1999.00749.x","volume":"113","author":"Austin","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0505","doi-asserted-by":"crossref","first-page":"xiv-xv","DOI":"10.1111\/j.0022-202X.2004.23488.x","article-title":"The IL-12 family member p40 chain as a master switch and novel therapeutic target in psoriasis","volume":"123","author":"Nestle","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0345","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2012.12.004_bb0350","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/sj.jid.5700310","article-title":"Prominent production of IL-20 by CD68+\/CD11c+ myeloid-derived cells in psoriasis: gene regulation and cellular effects","volume":"126","author":"Wang","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0355","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.clim.2007.01.006","article-title":"Immunobiologics in the treatment of psoriasis","volume":"123","author":"Chong","year":"2007","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0360","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMc070648","article-title":"Interleukin-12\/23 monoclonal antibody for psoriasis","volume":"356","author":"Okamoto","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2012.12.004_bb0365","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaad.2005.04.035","article-title":"Psoriasis\u2014recent advances in understanding its pathogenesis and treatment","volume":"53","author":"Krueger","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0510","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jaci.2010.03.018","article-title":"Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis","volume":"125","author":"Zaba","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0375","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","article-title":"Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis","volume":"366","author":"Papp","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2012.12.004_bb0515","doi-asserted-by":"crossref","first-page":"1190-9","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2012.12.004_bb0385","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1038\/jid.2012.163","article-title":"Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase i, randomized, placebo-controlled trial","volume":"132","author":"Papp","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0390","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4049\/jimmunol.0804080","article-title":"IL-17A controls IL-17F production and maintains blood neutrophil counts in mice","volume":"183","author":"von Vietinghoff","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.12.004_bb0395","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways","volume":"41","author":"Nair","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2012.12.004_bb0400","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/gene.2009.11","article-title":"Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis","volume":"10","author":"Elder","year":"2009","journal-title":"Genes Immun."},{"key":"10.1016\/j.clim.2012.12.004_bb0405","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/hmg\/6.8.1349","article-title":"Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan","volume":"6","author":"Nair","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.clim.2012.12.004_bb0410","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng1268","article-title":"A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis","volume":"35","author":"Helms","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2012.12.004_bb0415","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.0022-202X.2003.22104.x","article-title":"Evaluation of the IRF-2 gene as a candidate for PSORS3","volume":"122","author":"Foerster","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0420","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ng.310","article-title":"Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21","volume":"41","author":"Zhang","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2012.12.004_bb0425","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ng.313","article-title":"Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis","volume":"41","author":"de Cid","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2012.12.004_bb0430","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.ejhg.5200365","article-title":"Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden","volume":"7","author":"Enlund","year":"1999","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.clim.2012.12.004_bb0435","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/ejhg.2008.40","article-title":"Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5","volume":"16","author":"Vasilopoulos","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.clim.2012.12.004_bb0440","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/jmg.2008.065029","article-title":"Characterisation of psoriasis susceptibility locus 6 (PSORS6) in patients with early onset psoriasis and evidence for interaction with PSORS1","volume":"46","author":"Huffmeier","year":"2009","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.clim.2012.12.004_bb0445","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00439-007-0397-0","article-title":"Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis","volume":"122","author":"Capon","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.clim.2012.12.004_bb0450","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2012.12.004_bb0455","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1046\/j.1523-1747.2002.19612.x","article-title":"Evidence for a major psoriasis susceptibility locus at 6p21(PSORS1) and a novel candidate region at 4q31 by genome-wide scan in Chinese hans","volume":"119","author":"Zhang","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0460","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1523-1747.2003.12483.x","article-title":"Psoriasis susceptibility locus on 18p revealed by genome scan in Finnish families not associated with PSORS1","volume":"121","author":"Asumalahti","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0465","first-page":"12","article-title":"Th17 cells in MS and experimental autoimmune encephalomyelitis","volume":"16","author":"Hofstetter","year":"2009","journal-title":"Int. MS J."},{"key":"10.1016\/j.clim.2012.12.004_bb0470","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrrheum.2009.179","article-title":"IL-17 as a future therapeutic target for rheumatoid arthritis","volume":"5","author":"van den Berg","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0475","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmed.2009.12.005","article-title":"Pathogenesis of human systemic lupus erythematosus: recent advances","volume":"16","author":"Crispin","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.clim.2012.12.004_bb0480","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2012.12.004_bb0520","doi-asserted-by":"crossref","first-page":"1808-13","DOI":"10.1002\/ibd.21248","article-title":"IL-23\/IL-17 axis in IBD","volume":"16","author":"Sarra","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.clim.2012.12.004_bb0490","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2337\/db08-1113","article-title":"Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice","volume":"58","author":"Emamaullee","year":"2009","journal-title":"Diabetes"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161200294X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161200294X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T23:38:37Z","timestamp":1687909117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166161200294X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S152166161200294X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2012.12.004","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}